Publications:162
Paul J Kenny, PhD
About Me
Paul J. Kenny, PhD, is Ward-Coleman Professor and Chair of the Nash Family Department of Neuroscience. Dr. Kenny also serves as the Director of the Drug Discovery Institute and Director of the NIDA T32 Training Program in Substance Use Disorders at the Icahn School of Medicine at Mount Sinai. His multidisciplinary research involves the study of behavioral paradigms, physiological analyses, and the molecular underpinnings of neurobehavioral disorders. Dr. Kenny is actively investigating the brains of rodents to uncover new signaling cascades that may play a role in addiction-like behaviors. The Kenny Laboratory is focused on understanding the neurobiological mechanisms of drug addiction, obesity and schizophrenia, with an emphasis on the role of nicotinic acetylcholine receptors (nAChRs) in these processes. They employ a multidisciplinary approach that includes complex behavioral paradigms, physiological analyses and molecular biological techniques. Current projects include the utilization of vector-based delivery systems to modify gene expression in the brains of rodents to identify novel signaling cascades that may play a role in addiction-like behaviors. Search PubMed for articles
Contact
Nora McLaughlin
Executive Assistant to Paul Kenny
Phone: 212-824-8968 or ext. 58968
Email: nora.mclaughlin@mssm.edu
Language
Position
Research Topics
Addiction, Behavior, Brain, Drug Design and Discovery, Epigenetics, Gene Expressions, Molecular Biology, Neurobiology, Neuroscience, Obesity, Schizophrenia
Multi-Disciplinary Training Areas
Disease Mechanisms and Therapeutics (DMT), Genetics and Genomic Sciences [GGS]
About Me
Paul J. Kenny, PhD, is Ward-Coleman Professor and Chair of the Nash Family Department of Neuroscience. Dr. Kenny also serves as the Director of the Drug Discovery Institute and Director of the NIDA T32 Training Program in Substance Use Disorders at the Icahn School of Medicine at Mount Sinai. His multidisciplinary research involves the study of behavioral paradigms, physiological analyses, and the molecular underpinnings of neurobehavioral disorders. Dr. Kenny is actively investigating the brains of rodents to uncover new signaling cascades that may play a role in addiction-like behaviors. The Kenny Laboratory is focused on understanding the neurobiological mechanisms of drug addiction, obesity and schizophrenia, with an emphasis on the role of nicotinic acetylcholine receptors (nAChRs) in these processes. They employ a multidisciplinary approach that includes complex behavioral paradigms, physiological analyses and molecular biological techniques. Current projects include the utilization of vector-based delivery systems to modify gene expression in the brains of rodents to identify novel signaling cascades that may play a role in addiction-like behaviors. Search PubMed for articles
Contact
Nora McLaughlin
Executive Assistant to Paul Kenny
Phone: 212-824-8968 or ext. 58968
Email: nora.mclaughlin@mssm.edu
Language
Position
Research Topics
Addiction, Behavior, Brain, Drug Design and Discovery, Epigenetics, Gene Expressions, Molecular Biology, Neurobiology, Neuroscience, Obesity, Schizophrenia
Multi-Disciplinary Training Areas
Disease Mechanisms and Therapeutics (DMT), Genetics and Genomic Sciences [GGS]